Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group
J P Guastalla, J B Vermorken, J A Wils, et al.
Seminars in Oncology
|
October 1, 1994
Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort
G Giaccone, M Huizing, W ten Bokkel Huinink, et al.
Urology
|
April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trials
R Hall, P O Hedlund, R Ackermann, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study
C F de Oliveira, A J Lacave, C Villani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix
J. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
G Giaccone, O Dalesio, G J McVie, et al.
The New England Journal of Medicine
|
August 30, 1990
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
R J Slebos, R E Kibbelaar, O Dalesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2013
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study
J G Aerts, H Codrington, N A G Lankheet, et al.
Seminars in Oncology
|
February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute
W W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
British Journal of Cancer
|
April 17, 1999
Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification
J W Baars, D de Jong, E M Willemse, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group
J P Guastalla, J B Vermorken, J A Wils, et al.
Seminars in Oncology
|
October 1, 1994
Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort
G Giaccone, M Huizing, W ten Bokkel Huinink, et al.
Urology
|
April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trials
R Hall, P O Hedlund, R Ackermann, et al.
European Journal of Gynaecological Oncology
|
January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study
C F de Oliveira, A J Lacave, C Villani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Phase II study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix
J. B. Vermorken, C. Mangioni, S. Pecorelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
G Giaccone, O Dalesio, G J McVie, et al.
The New England Journal of Medicine
|
August 30, 1990
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
R J Slebos, R E Kibbelaar, O Dalesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2013
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study
J G Aerts, H Codrington, N A G Lankheet, et al.
Seminars in Oncology
|
February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer Institute
W W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
British Journal of Cancer
|
April 17, 1999
Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification
J W Baars, D de Jong, E M Willemse, et al.
Page
of 8